Joint Innovations
We have developed a non-degradable synthetic implant designed to mechanically function in a similar way to the native tissue, while also enabling robust fixation at the site of implantation. Team: Suzanne Maher
Read MoreEinstein
We have identified oxytocin as a novel and powerful anti-obesity agent; we propose to form a company to develop the next-generation oxytocin analogs with improved properties. Team: Sudarshana Purkavastha
Read MoreVivPure
My technology is the development of antibacterial metal surfaces and implementation into the food industry. Pure Nano provides a process for coating metal machinery which comes in contact with food at the mass scale production level with an antibacterial treatment. Team: Yazmin Feliz – Founder
Read MoreCardea Sciences
Heart monitor for risk evaluation of adverse events and worsening symptoms in atrial fibrillation patients based on pulse-deficit measurement. Team: Dr. Ya-El Mandel-Portnoy – Founder & CEO Dr. Gregor Schwartz – Head of R&D
Read MoreZLife Technologies
We have developed and patented a novel preservation solution to be used as a clinical treatment for ischemia-reperfusion injury in organ transplantation, particularly intestinal transplantation. Team: Ming Zhang, MD, PhD. – President, CEO Xiang Li Andrew Hitchings
Read MoreOstoCare
OstoCare is an integrated solution for ostomy patients designed to reduce odors and leakage while simplifying the difficult ostomy bag changing process. Team: Wilson Ho
Read MoreUnicrobe
We will provide bacterial genome editing services using CRISPR-Cas technologies for academic and industrial customers interested in improving human health and developing bacterial technologies. Team: Wenyan Jiang – CEO, CSO Yuchen Qi – Business Development
Read MoreiLight Biotechnologies
Genetic tools for non-invasive activation and detection of biological processes with deeply penetrating near-infrared light that will make drug discovery process more efficient. iLight Biotechnologies Team: Daria Shcherbakova, PhD. – Co-founder, CEO Vladislav Verkhusha, PhD. – Co-founder, CSO
Read MoreMirna Analytics
Mirna Analytics is developing a non-invasive platform tool for prognostic and diagnostic monitoring. Our current focus is on pulmonary hypertension. Team: Gabriele Grunig, DVM, PhD – Co-founder, President Serhiy Pylawka, RN, MS – Co-founder, Science Officer
Read MoreMouSensor, Inc.
MouSensors provide the first genetic platform for smell pharmacology to assist humans in scent detection tasks such as non-invasive cancer diagnosis, Tuberculosis identification, explosives detection etc. Team: Paul Feinstein, PhD. – Co-founder Charlotte D’Hulst, PhD. – Co-founder
Read More